Harnessing Nature for Faster mRNA Vaccine Manufacturing

Manufacturing capacity is often decried as a major bottleneck in administering COVID-19 vaccines to a global population of 7.8 billion. For mRNA vaccines, which can make 1 million doses in a 2-liter bioreactor, the bottleneck is the availability of raw materials, not bioreactors.